The Philippine Health Insurance Corp. (PhilHealth) released Advisory 2021-039 to inform the public about the guidelines in claiming the COVID-19 Vaccine Injury Compensation Package and the benefits under the National Health Insurance Program. The COVID-19 National Vaccine Indemnity Fund, established under the COVID-19 Vaccination Program Act of 2021 (Republic Act 11525), would compensate inoculated persons in case of death, permanent disability and hospital confinement for serious adverse effects of the vaccine.

Under the NHIP, all Filipinos, including those who will claim for the vaccine injury compensation, are eligible for PhilHealth benefits. For hospital confinement, the inpatient benefits shall be based on the applicable case rates. The case rate amount is inclusive of hospital charges and professional fees of attending physicians. It shall be deducted from the hospital bill and shall be claimed by the hospitals through the usual process and procedures.

Hospitalizations due to vaccine product-related or vaccine quality defect-related reactions are compensable under the COVID-19 Vaccine Injury Compensation Package. Below are the package rates and benefit cap:

The claims shall be filed directly by the claimants or their beneficiary at the nearest PhilHealth office and must be processed separately from inpatient benefits based on the guidelines defined in PhilHealth Circular 2021-0007.

Please be guided accordingly.



P&A Grant Thornton

Certified Public Accountants


As published in SunStar Cebu, dated 20 October 2021